Germany
· Delayed Price · Currency is EUR AlzChem Group AG Statistics
Total Valuation
AlzChem Group AG has a market cap or net worth of EUR 580.05 million. The enterprise value is 539.44 million.
| Market Cap | 580.05M |
| Enterprise Value | 539.44M |
Important Dates
The next estimated earnings date is Friday, February 28, 2025.
| Earnings Date | Feb 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 5.01M |
Valuation Ratios
The trailing PE ratio is 11.58.
| PE Ratio | 11.58 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 3.07 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.42, with an EV/FCF ratio of 6.54.
| EV / Earnings | 10.77 |
| EV / Sales | 0.96 |
| EV / EBITDA | 5.42 |
| EV / EBIT | 7.28 |
| EV / FCF | 6.54 |
Financial Position
The company has a current ratio of 2.32
| Current Ratio | 2.32 |
| Quick Ratio | 1.39 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 20.64 |
Financial Efficiency
Return on equity (ROE) is 28.41% and return on invested capital (ROIC) is 26.19%.
| Return on Equity (ROE) | 28.41% |
| Return on Assets (ROA) | 10.19% |
| Return on Capital (ROIC) | 26.19% |
| Revenue Per Employee | 350,682 |
| Profits Per Employee | 31,175 |
| Employee Count | 1,708 |
| Asset Turnover | 1.24 |
| Inventory Turnover | 1.85 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +125.48% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +125.48% |
| 50-Day Moving Average | 57.46 |
| 200-Day Moving Average | 48.40 |
| Relative Strength Index (RSI) | 49.66 |
| Average Volume (20 Days) | 336 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AlzChem Group AG had revenue of EUR 563.55 million and earned 50.10 million in profits. Earnings per share was 4.93.
| Revenue | 563.55M |
| Gross Profit | 348.81M |
| Operating Income | 74.14M |
| Pretax Income | 69.90M |
| Net Income | 50.10M |
| EBITDA | 97.56M |
| EBIT | 74.14M |
| Earnings Per Share (EPS) | 4.93 |
Balance Sheet
| Cash & Cash Equivalents | 40.62M |
| Total Debt | n/a |
| Net Cash | 40.62M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 192.49M |
| Book Value Per Share | 18.92 |
| Working Capital | 151.68M |
Cash Flow
In the last 12 months, operating cash flow was 103.05 million and capital expenditures -20.56 million, giving a free cash flow of 82.49 million.
| Operating Cash Flow | 103.05M |
| Capital Expenditures | -20.56M |
| Free Cash Flow | 82.49M |
| FCF Per Share | n/a |
Margins
Gross margin is 61.90%, with operating and profit margins of 13.16% and 8.89%.
| Gross Margin | 61.90% |
| Operating Margin | 13.16% |
| Pretax Margin | 12.40% |
| Profit Margin | 8.89% |
| EBITDA Margin | 17.31% |
| EBIT Margin | 13.16% |
| FCF Margin | 14.64% |
Dividends & Yields
AlzChem Group AG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | 14.29% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 24.38% |
| Buyback Yield | -0.03% |
| Shareholder Yield | -0.03% |
| Earnings Yield | 8.52% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on July 1, 2019. It was a reverse split with a ratio of 0.1.
| Last Split Date | Jul 1, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |